Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals
Daniel A. Duprez, Jacqueline Neuhaus, Lewis H. Kuller, Russell P. Tracy, Waldo Horacio Belloso, Stéphane De Wit, Fraser Drummond, Henry Clifford Lane, Bruno Ledergerber, Jens Dilling Lundgren, Daniel E. Nixon, Nicholas I. Paton · 2012
Read Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals by Daniel A. Duprez, Jacqueline Neuhaus, Lewis H. Kuller, Russell P. Tracy, Waldo Horacio Belloso, Stéphane De Wit, Fraser Drummond, Henry Clifford Lane, Bruno Ledergerber, Jens Dilling Lundgren, Daniel E. Nixon, Nicholas I. Paton (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w2123354892.txt.
Description
Daniel Duprez, Jacqueline Neuhaus, Lewis Kuller, and colleagues published this study in PLoS ONE in 2012. They worked with the SMART trial, which compared steady HIV treatment with planned treatment breaks. Their question was whether blood markers of swelling and clotting could predict heart and vessel disease in people living with HIV.
Blood samples came from more than five thousand trial participants. The team measured three markers linked to inflammation and clotting and tracked heart events. The wider trial had already shown that treatment breaks raised heart risk despite lower drug exposure. The study tests whether these markers add warning power beyond the usual risk factors doctors already measure.
Catalog record
| CREATOR | Daniel A. Duprez, Jacqueline Neuhaus, Lewis H. Kuller, Russell P. Tracy, Waldo Horacio Belloso, Stéphane De Wit, Fraser Drummond, Henry Clifford Lane, Bruno Ledergerber, Jens Dilling Lundgren, Daniel E. Nixon, Nicholas I. Paton |
|---|---|
| YEAR | 2012 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | OpenAlex / PLoS ONE |